Received Jan 21, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 3 | W1C741M | OT / LL |
administration of an expired ipol dose with no reported adverse event; Initial information received on 14-Jan-2026 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 6 years old male patient who was administered with an expired dose of suspect IPV (VERO) [IPOL] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Diphtheria vaccine toxoid, Pertussis vaccine acellular 3-component, Tetanus vaccine toxoid (Infanrix) for Immunisation. On 14-Jan-2026, the patient received 0.5 ml expired (dose 3) of suspect IPV (VERO), Suspension for injection, lot W1C741M,expiry date 17-Nov-2025, frequency: once, Strength: Standard via intramuscular route in the left vastus lateralis for Immunization with no reported adverse event (expired product administered) (latency: same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Infanrix